NASDAQ · HURA
TuHURA Biosciences, Inc.
$2.06+$0.07 (+3.52%)
TuHURA Biosciences, Inc.’s quoted price sits in the upper half of its reported 52-week range, 39.94% below the high.
Loading market information…
NASDAQ · REUN · USD
Stock price, earnings
Quote as of Jul 31, 2023, 07:59 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Reunion Neuroscience Inc.’s quoted price sits in the lower half of its reported 52-week range, 94.8% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Reunion Neuroscience Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Field Trip Health Ltd. is a North American company specializing in the development and delivery of psychedelic-assisted therapies. The organization operates Field Trip Health Centres, which offer psychedelic-based treatments, and provides digital applications under the Field Trip brand. Additionally, its Field Trip Discovery division focuses on researching and creating next-generation psychedelic molecules. The company also administers ketamine-assisted therapy to address various conditions, including depression, anxiety, and addiction. Established in 2008, Field Trip Health Ltd. is based in Toronto, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:28 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q2 2022 | Nov 15, 2021 | -$1.15-17.35% vs estimate | $716.09K-49.92% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$2.06+$0.07 (+3.52%)
TuHURA Biosciences, Inc.’s quoted price sits in the upper half of its reported 52-week range, 39.94% below the high.
$4.58$0.00 (0.0%)
Axcella Health Inc.: Healthcare · Biotechnology.
€0.21-€0.01 (-2.38%)
Celyad Oncology S.A.’s quoted price sits in the lower half of its reported 52-week range, 68.46% below the high.
$0.84+$0.01 (+1.07%)
Field Trip Health Ltd.: Healthcare · Medical - Care Facilities.
$0.57-$0.26 (-30.77%)
Kineta, Inc.’s quoted price sits in the lower half of its reported 52-week range, 89.34% below the high.
$0.83+$0.00 (+0.35%)
Imunon, Inc.’s quoted price sits in the lower half of its reported 52-week range, 82.61% below the high.
$0.25-$0.09 (-27.68%)
Notable Labs, Ltd.’s quoted price sits in the lower half of its reported 52-week range, 94.15% below the high.
$0.02$0.00 (0.0%)
SQZ Biotechnologies Company’s quoted price sits in the lower half of its reported 52-week range, 65.71% below the high.
